Local Institution

Maastricht 6229 HX

0 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndromes, Advanced Non-small Cell Lung Cancer, Deep-Vein Thrombosis, Gastric/Esophageal Adenocarcinoma, HIV Infections, Non-small Cell Lung Cancer, Pancreatic Cancer Including Ampulla of Vater, Soft Tissue Sarcoma, Transitional Cell Carcinoma, Unresectable or Metastatic Melanoma

Studies at this site

• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types — Completed
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study — Completed
• Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) — Stopped early